News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis
Vincent Rajkumar/X
May 12, 2025, 10:53

Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared an article on X:

“Solitary plasmacytoma.

One lesion, but 3 possible entities with differing prognosis in the differential diagnosis.

Outcomes and management.”

Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes.

Authors: Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, Moritz Binder, Francis K. Buadi, Joselle Cook, David Dingli, Angela Dispenzieri, Amie L. Fonder, Morie A. Gertz, Wilson Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar.

You can read the Full Article on Journal of Blood Advances.

Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis

More posts featuring Vincent Rajkumar.

Amie L Fonder Angela Dispenzieri cancer Charalampos Charalampous David Dingli diagnosis fight against cancer Francis K. Buadi Global fight against cancer Jean-Sebastien Claveau Joselle Cook Martha Q Lacy Mayo Clinic Miriam A Hobbs Morie A Gertz Moritz Binder Nelson Leung OncoDaily Oncology Prashant Kapoor prognosis Rahma Warsame Robert A. Kyle Rochester S Vincent Rajkumar Shaji K. Kumar Solitary Plasmacytoma Suzanne R Hayman Taxiarchis Kourelis Vincent Rajkumar Wilson Gonsalves Yi L. Hwa Yi Lin
Special Coverage
Blog
Jun 4, 2025, 00:35
Ruben Mesa: Important work in Pharmacogenomics around DPYD at ASCO25
Blog
Jun 4, 2025, 00:12
Dinesh Raj Neupane: Paying the Price for Distance: Travel-Driven Financial Toxicity Among Cancer Patients in Nepal
Blog
Jun 3, 2025, 20:49
Tracey O’Brien: Excited to Announce Speakers for the Inaugural NSW Cancer Summit 2025
Insight
Jun 3, 2025, 18:29
Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC
Insight
Jun 3, 2025, 18:25
From Political Will to Global Wake-Up Call: Hesham ElGhazaly on Egypt’s National Cancer Strategy at ASCO 2025
Insight
Jun 3, 2025, 18:19
Clifford Hudis and Thomas Kurian Discussed AI in Oncology and ASCO Guidelines Assistant at ASCO 2025
Insight
Jun 3, 2025, 18:18
Elizabeth McKenna: Study on Vascular Normalization and Enhanced Immunotherapy
Insight
Jun 3, 2025, 17:25
Mohammad Jad Moussa: Huge Congrats to My Future Co-Resident Sam Black on This ASCO 2025 Feat
Insight
Jun 3, 2025, 17:21
Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025
Insight
Jun 3, 2025, 16:58
Paolo Tarantino Presented DATO-Base Trial Poster at ASCO 2025 on Breast Cancer CNS Metastases
Insight
Jun 3, 2025, 16:39
Pashtoon Kasi: This Is the 1st Time I Started Hearing the Word “CURE” in Patients with Metastatic Stage-IV Cancers
Blog
Jun 3, 2025, 16:39
Massimo Di Maio: Standing Ovation for CHALLENGE phase 3 trial at ASCO25